BNP Paribas Financial Markets
VIR icon

BNP Paribas Financial Markets’s Vir Biotechnology VIR Stock Holding History

BNP Paribas Financial Markets’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66M Sell
653,692
-424,328
-39% -$4.04M ﹤0.01% 1898
2026
Q1 		$9.66M Buy
1,078,020
+798,344
+285% +$6.36M ﹤0.01% 1579
2025
Q4 		$1.69M Buy
279,676
+260,530
+1,361% +$1.55M ﹤0.01% 2744
2025
Q3 		$109K Buy
19,146
+8,906
+87% +$45.5K ﹤0.01% 4255
2025
Q2 		$51.6K Sell
10,240
-30,593
-75% -$164K ﹤0.01% 4249
2025
Q1 		$265K Buy
40,833
+28,343
+227% +$252K ﹤0.01% 3552
2024
Q4 		$91.7K Buy
+12,490
New +$98.5K ﹤0.01% 4181

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Financial Markets's VIR Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Vir Biotechnology (VIR) stake by 39% in Q2 2026, selling an estimated $4.04M and leaving 653,692 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1898.

BNP Paribas Financial Markets first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.66M in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • BNP Paribas Financial Markets held 653,692 shares of Vir Biotechnology worth $6.66M as of Q2 2026.
  • BNP Paribas Financial Markets sold 424,328 Vir Biotechnology shares in Q2 2026, an estimated $4.04M.
  • Vir Biotechnology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1898 holding.
  • BNP Paribas Financial Markets first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Vir Biotechnology position peaked at $9.66M in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.